BTG3 and infection: Forty-five AEs (19.7 AE/100 ANA exposure years, 95%CI: 14.4–26.4) were reported in 43/78 (55%) patients including infections, elevated transaminases (at least two-fold increased), neutropenia, headache, trypanophobia and local site reactions (Table 5).